The Traderszone Network

Published in TZ Latest News 13 April, 2017 by The TZ Newswire Staff

Valeant Pharmaceuticals’ Market Cap Is Now Lower Than Its Projected Full-Year EBITDA

The hits just keep on coming for embattled drugmaker Valeant Pharmaceuticals (NYSE: VRX).

read more